Litigation

Recent Posts

Kentucky Appeals Court Vacates $130 Million Drug-Pricing Verdicts, Says State Was 'Complicit'
Posted on 16 Oct 2012 by Tom Moylan

FRANKFORT, Ky. - A Kentucky appeals court panel on Oct. 12 vacated verdicts totaling more than $130.7 million against two drug makers for publishing inflated average wholesale prices (AWPs), saying the Kentucky Medicaid program was well aware of the practice... Read More

Tags: pharmacies , drug pricing , average wholesale prices , Sandoz , Kentucky appeals court , Kentucky Medicaid program , AstraZeneca , Kentucky Medicaid Fraud Statute , compensatory damages , verdicts , drug makers , False Advertising Statute , Medicaid , Sandoz Inc. v. Commonwealth of Kentucky , Litigation , Kentucky attorney general , LP v. Commonwealth of Kentucky , AWPs , Consumer Protection Act , First DataBank

Wisconsin To Get $4 Million In Multistate Drug Lawsuit
Posted on 12 May 2010 by LexisNexis Litigation Resource Community Staff

MADISON Wis. – (AP) Attorney General J.B. Van Hollen said Tuesday that Wisconsin will get more than $4 million in a multistate settlement with drug manufacturer AstraZeneca. The drug maker allegedly marketed the anti-psychotic drug Seroquel for... Read More

Tags: AstraZeneca , anti-psychotic drug , J.B. Van Hollen , drug makers , Litigation , lawsuit , insomnia , Wisconsin , Seroquel

Parents Lose Supreme Court Appeal In Vaccine Case
Posted on 22 Feb 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court closed the courthouse door Tuesday to parents who want to sue drug makers over claims that their children developed autism and other serious health problems from vaccines. The ruling was a stinging defeat for... Read More

Tags: Supreme Court , DPT , Vaccine Act , Wyeth , Bruesewitz , Pfizer , autism , diphtheria , drug makers , American Academy of Pediatrics , pertussis , vaccine , Litigation , tetanus , vaccine court , lawsuit , Bruesewitz v. Wyeth

Pfizer Stock Sold, Roberts To Hear Company's Cases
Posted on 29 Sep 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) Chief Justice John Roberts has sold his shares of Pfizer Inc., a move that allows him to participate in two pending Supreme Court cases involving the pharmaceutical maker. Federal law requires judges to sit out cases if they own... Read More

Tags: Supreme Court , smoking cessation , Elena Kagan , Pfizer , Richard Thornburgh , drug makers , Chief Justice John Roberts , pharmaceutical maker , Litigation , Antonin Scalia , lawsuit , Pat Leahy , tobacco